CNV analysis with Euformatics Genomics Hub
Copy Number Variations (CNVs) refer to alterations in the DNA of a genome that result in cells having an abnormal number of copies of one or more
PRESS RELEASE | Euformatics expands in the Middle East in partnership with Zahrawi Medical Group for Bahrain, Oman and the UAE markets
Espoo, Finland, May 2023. Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools,
Streamlining NGS Testing: A Modular Solution with Euformatics Genomics Hub
Automation is a critical component of NGS testing and Euformatics Genomics Hub is leading the way with innovative solutions. With an ever-increasing
PRESS RELEASE | Euformatics and ViennaLab join forces to develop a complete and efficient solution for species level classification of the human gut microbiome.
Espoo, Finland, March 2023. Research points out that microorganisms play a role in many aspects of human health. Consequently, more and more people
Webinar | Validating an NGS pipeline with concordance analysis
Go to recorded webinar. NGS (Next-Generation Sequencing) is a powerful technology that allows researchers to quickly and efficiently sequence
PRESS RELEASE | Euformatics, in partnership with ViennaLab Diagnostics and Oncompass Medicine, awarded a contract to research and develop an end-to-end liquid biopsy solution for eight leading European oncology centers
Espoo, Finland, February 2023. Euformatics, a global leader in NGS data quality control and variant interpretation, together with ViennaLab
PRESS RELEASE | Folkhälsan Research Center chooses Euformatics Genomics Hub end to end solution for clinical research of NGS patient data
Espoo, Finland, January 2023. Folkhälsan Research Center, has chosen Euformatics as the provider of NGS secondary analysis and variant